MTOR and prostate carcinoma: Moreover, cuproptosis improved chemosensitivity to docetaxel in prostate cancer cell lines by hindering autophagy via the dihydrolipoamide S-acetyltransferase (DLAT)/mammalian target of rapamycin (mTOR) pathway (106).